Feedback
The current prices are delayed. Login to see live prices.

Solara Active Pharma Sciences Ltd.

(SOLARA)

401234567899012345678910123456789.1012345678900123456789
+23.10 (+4.94%)
Updated 15:45 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Previous Close: 468
Today's low
₹465.00
Today's high
₹491.4
52 week low
₹355.1
52 week high
₹882.8
Open
₹479.95
Prev Close
₹468
Volume (shares)
185,641
Total Trading Value
8.69 Cr

Technicals

SMA
Value
Signal
12-SMA
502.67
Bearish
20-SMA
507.89
Bearish
50-SMA
608.85
Bearish
100-SMA
693.81
Bearish
200-SMA
644.37
Bearish

Discussions

  •  Yesterday 12:14 AM
Solara Active Pharma Sciences Grants 3,50,000 ESOP Options
• Solara Active Pharma Sciences has granted 3,50,000 ESOP options to...read more

  •  Yesterday 12:14 AM
Solara Active Pharma Announces Closure of Unproductive Subsidiary
• Solara Active Pharma Sciences Limited has announced the closure of...read more

  •  Feb 10 9:27 PM
CRISIL Ratings Submission: Monitoring Agency Report for Solara
• The Monitoring Agency Report confirms the proper utilization of pr...read more

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Solara Active Pharma Sciences Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Solara Active Pharma Sciences Ltd. is Rs 468 as of 21 February 2025.

What is the Market Capitalization of Solara Active Pharma Sciences Ltd. ?

The current market cap of Solara Active Pharma Sciences Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Solara Active Pharma Sciences Ltd.?

Solara Active Pharma Sciences Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of Solara Active Pharma Sciences Ltd.?

The 52-week high of Solara Active Pharma Sciences Ltd. is Rs 882.8 and the 52-week low is Rs 355.1
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025